<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Izadi Z</submitter><pubmed_abstract>Ischemic stroke accompanies oxidative stress and cell death in the cerebral tissue. The microRNA miR-34a plays a pivotal role in this molecular pathology. This study presents the rational repositioning of aminoglycosidic antibiotics as miR-34a antagonists in order to assess their efficiency in protecting the PC12 stroke model cells from oxidative stress occurring under cerebral ischemic conditions. A library of 29 amino-sugar compounds were screened against anticipated structural models of miR-34a through molecular docking. MiR-ligand interactions were mechanistically studied by molecular dynamics simulations and free-energy calculations. Cultured PC12 cells were treated by H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> alone or in combination with gentamycin and neomycin as selected drugs. Cell viability and apoptosis were detected by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and annexin V-FITC/propidium iodate (PI) double staining assays, respectively. The expression levels of key factors involved in cell proliferation, oxidative stress, and apoptosis in treated PC12 cells were measured through a quantitative real-time polymerase chain reaction and flow cytometric annexin V-FITC/PI double staining assays. A stable and energetically favorable binding was observed for miR-34a with gentamycin and neomycin. Gentamycin pretreatments followed by H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> oxidative injury led to increased cell viability and protected PC12 cells against H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-induced apoptotic events. This study will help in further understanding how the suppression of miR-34a in neural tissue affects the cell viability upon stroke.</pubmed_abstract><journal>ACS omega</journal><pagination>771-781</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9835649</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gentamycin Rationally Repositioned to Inhibit miR-34a Ameliorates Oxidative Injury to PC12 Cells.</pubmed_title><pmcid>PMC9835649</pmcid><pubmed_authors>Derakhshankhah H</pubmed_authors><pubmed_authors>Izadi Z</pubmed_authors><pubmed_authors>Barzegari E</pubmed_authors><pubmed_authors>Sajadimajd S</pubmed_authors><pubmed_authors>Iranpanah A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gentamycin Rationally Repositioned to Inhibit miR-34a Ameliorates Oxidative Injury to PC12 Cells.</name><description>Ischemic stroke accompanies oxidative stress and cell death in the cerebral tissue. The microRNA miR-34a plays a pivotal role in this molecular pathology. This study presents the rational repositioning of aminoglycosidic antibiotics as miR-34a antagonists in order to assess their efficiency in protecting the PC12 stroke model cells from oxidative stress occurring under cerebral ischemic conditions. A library of 29 amino-sugar compounds were screened against anticipated structural models of miR-34a through molecular docking. MiR-ligand interactions were mechanistically studied by molecular dynamics simulations and free-energy calculations. Cultured PC12 cells were treated by H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> alone or in combination with gentamycin and neomycin as selected drugs. Cell viability and apoptosis were detected by 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and annexin V-FITC/propidium iodate (PI) double staining assays, respectively. The expression levels of key factors involved in cell proliferation, oxidative stress, and apoptosis in treated PC12 cells were measured through a quantitative real-time polymerase chain reaction and flow cytometric annexin V-FITC/PI double staining assays. A stable and energetically favorable binding was observed for miR-34a with gentamycin and neomycin. Gentamycin pretreatments followed by H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub> oxidative injury led to increased cell viability and protected PC12 cells against H&lt;sub>2&lt;/sub>O&lt;sub>2&lt;/sub>-induced apoptotic events. This study will help in further understanding how the suppression of miR-34a in neural tissue affects the cell viability upon stroke.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T08:25:41.707Z</modification><creation>2025-04-04T08:25:41.707Z</creation></dates><accession>S-EPMC9835649</accession><cross_references><pubmed>36643496</pubmed><doi>10.1021/acsomega.2c06112</doi></cross_references></HashMap>